It is worthy to note that DHFR inhibition, either by Methotrexate (MTX) or EphB activation with synthetic ligands, has been previously reported to reduce the self-renewing potential of brain tumor-initiating cells [38]. This evidence concerns the gene DHFR and brain neoplasm.